Spyre Therapeutics (SYRE) Return on Sales Growth (3y) (2018 - 2022)
Spyre Therapeutics (SYRE) Return on Sales Growth (3y) (2018 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn | 1.00 |
| 10 | Spyre Therapeutics | 255.85 Mn | 255.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 7.00 |
| Dec 31, 2021 | 7.00 |
| Sep 30, 2021 | 6.00 |
| Jun 30, 2021 | 4.00 |
| Mar 31, 2019 | -20.00 |
| Dec 31, 2018 | -8.00 |
| Sep 30, 2018 | -4.00 |
| Jun 30, 2018 | -4.00 |